Consumer Lawyers

Actos and a Bladder Cancer Risk?

In Uncategorized on November 19, 2011 at 11:40 pm

Our office is investigating the link between Actos and Bladder Cancer, 404-451-7781.

Recent Studies by the FDA has  linked the diabetes medication Actos, which contains pioglitazone, to an increased risk of bladder cancer compared to other anti-diabetesdrugs. Actos is prescribed, along with diet and exercise, to control Type 2 Diabetes.

Between January 2010 and October 2010, approximately 2.3 million patients filled a prescription for Actos, which is manufactured in San Diego, California by Takeda Pharmaceuticals North America, at outpatient pharmacies across America.

In September of 2010, following a five-year review and analysis of patient data, the FDA reported that while there was no major increased risk of bladder cancer with pioglitazone use, the agency did note an increased risk of bladder cancer among patients with the longest exposure to pioglitazone, and in those exposed to the highest cumulative dosage.

 

http://www.usrecallnews.com/2011/11/actos-bladder-cancer.html

Enhanced by Zemanta
Advertisements

Leave a Reply

Please log in using one of these methods to post your comment:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: